nach oben

Reactions Weekly

Erschienen in:

01.06.2019 | Case report

Anlotinib

Proteinuria: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

An approximately 77-year-old man developed proteinuria during treatment with anlotinib for gastric adenocarcinoma. …

Li Q, et al. Long-term survival of an elderly patient with advanced gastric cancer after combination therapy: A case report and literature review. BMC Cancer 19: 459, No. 1, 2019. Available from: URL: http://doi.org/10.1186/s12885-019-5683-4 - China

Titel: Anlotinib
Proteinuria: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63578-3

Apixaban/edoxaban

Case report

Antineoplastics

Case report

Cyclophosphamide/rituximab

Case report

Ciclosporin/mycophenolate

Case report

Morphine

Case report

90y-dotatate/lutetium-(177lu)-oxodotreotide

Case report

Springer Medizin

Anlotinib

Proteinuria: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Apixaban/edoxaban

Antineoplastics

Cyclophosphamide/rituximab

Ciclosporin/mycophenolate

Morphine

90y-dotatate/lutetium-(177lu)-oxodotreotide

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Apixaban/edoxaban

Antineoplastics

Cyclophosphamide/rituximab

Ciclosporin/mycophenolate

Morphine

90y-dotatate/lutetium-(177lu)-oxodotreotide